2nd International Conference of the Spanish Society of Metabolomics (SESMet 2024), Sevilla, İspanya, 03 Haziran 2024, ss.27-28
Obesity
represents the leading cause of several noncommunicable diseases, including
type 2 diabetes mellitus (T2DM). In fact, the associated risk of developing
T2DM in overweighed individuals is enormously high. Nevertheless, the
mechanisms at the basis of this relationship are far from being understood and
rely on complex interplays between glucose homeostasis, inflammation and autoimmunity.
Polymeric immunoglobulin receptor (pIgR) plays a central role in mucosal immunity by facilitating IgA translocation across epithelial barriers during the immune response. High fat diet (HFD) is well-known to trigger several immunogenic events and has been associated to altered IgA frequency and production in mice. Furthermore, HFD-fed-IgA-deficient mice show exacerbated adipose tissue inflammation and disrupted glucose and host-microbiome homeostasis, suggesting a possible involvement of pIgR in obesity-induced insulin resistance (IR).
In order to understand the role of pIgR and IgA during the onset of T2DM, we applied GC-MS-based untargeted metabolomics to characterized metabolites alterations in serum, liver and visceral white adipose tissue (vWAT) in the pIgR−/− murine model of obesity-induced IR.
Following
metabolite extraction, supernatant was dried-out and submitted to a two-step
derivatization process consisting of methoximation and sylilation. The amount
of reagents and sample was optimized to achieved the best recovery. Samples
were analyzed using an 8890 Agilent GC-system coupled to the LECO Pegasus
BT-TOF-MS. Data processing, including deconvolution, alignment and metabolites
identification were performed using LECO ChromaTOFSync. Low analytical
variability was confirmed through quality assurance, with statistical analysis
revealing significant differences in carbohydrates, fatty acids, nucleic acids
and
organic acids across serum, liver, and vWAT.
The identified alterations could serve as pivotal indicators, shedding light on the complex mechanisms underlying T2DM onset in an obesogenic environment. This study underscores the importance of PIgR and IgA in modulating metabolic processes and highlights the potential of metabolomics in elucidating disease pathogenesis and identifying therapeutic targets.